Reducing Problematic Substance Use in Youth With Chronic Medical Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Withdrawn
- Sponsor
- Boston Children's Hospital
- Locations
- 1
- Primary Endpoint
- Percent days abstinent
Study Overview
Brief Summary
The investigators goal is to pilot a substance use-related brief intervention (BI) for youth with chronic medical conditions, obtaining preliminary evidence of feasibility, acceptability and impacts of the approach for reducing substance use among this group.
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 14 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •14-18 years old
- •Currently being treated for diabetes, rheumatologic disorders, asthma, or ulcerative colitis (UC) at Boston Children's Hospital with a duration of chronic illness of at least one year
- •Previous participation in the screening validation study
- •Evidence of problems related to substance use
Exclusion Criteria
- •Medically or emotionally unstable or otherwise unable to provide assent/consent
- •Unable to speak/read English
- •Unable to use a computer keyboard and/or complete an interviewer-assisted questionnaire
Arms & Interventions
Treatment as Usual
Those in the Treatment as Usual group will not receive the brief intervention for substance use but will receive a brief health education brochure.
Brief Intervention
Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use.
Intervention: Brief Intervention (Behavioral)
Outcomes
Primary Outcomes
Percent days abstinent
Time Frame: 30 days post baseline
We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline
Secondary Outcomes
- Medical complications(30 days post baseline)
Investigators
Sharon Levy
Assistant Professor of Pediatrics, Harvard Medical School
Boston Children's Hospital